Where is Gemini Therapeutics headquartered?

Gemini Therapeutics is located in Cambridge, MA.

Who invested in Gemini Therapeutics?

Gemini Therapeutics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Gemini Therapeutics raised to date?

Gemini Therapeutics has raised ____.

When was the last funding round for Gemini Therapeutics?

Gemini Therapeutics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

geminitherapeutics.com

Gemini Therapeutics

Gemini is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of macular degeneration diseases.

Business Model:

Revenue: $0

Employees: 11-50

Geographic Data

Address: 300 One Kendall Square

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$95M

Raised Total:

$140M

Social

Twitter

Crunchbase

Metrics

3,480,430Website Global Rank

4,098Website Monthly Traffic

Twitter Followers

Description

Gemini is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of macular degeneration diseases.

Contact Phone:
+16174014400

Contact Email:

IPO Details

Gemini Therapeutics went public on 2/8/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/8/2021

Ticker Symbol:
GMTX

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
2/2021	IPO SPAC		$216M
10/2017	Series A	3	$42.5M	Atlas Venture Lightstone Ventures OrbiMed Atlas Venture Lightstone Ventures OrbiMed
4/2016	Seed Round	3	$2M	Lightstone Ventures OrbiMed Atlas Venture Lightstone Ventures
2/2021	Post-IPO Equity		$0	Acorn Bioventures Alyeska Investment Group Atlas Venture Boxer Capital Dafna Capital Management Fidelity Management and Research Company Foresite Capital Lightstone Ventures OrbiMed Suvretta Capital Management Wellington Management Wu Capital Acorn Bioventures Alyeska Investment Group Atlas Venture Boxer Capital Dafna Capital Management Fidelity Management and Research Company Foresite Capital Lightstone Ventures OrbiMed Suvretta Capital Management Wellington Management Wu Capital
2/2021	Post-IPO Equity	12	$95M	Acorn Bioventures Alyeska Investment Group Atlas Venture Boxer Capital Dafna Capital Management Fidelity Management and Research Company Foresite Capital Lightstone Ventures OrbiMed Suvretta Capital Management Wellington Management Wu Capital Acorn Bioventures Alyeska Investment Group Atlas Venture Boxer Capital Dafna Capital Management Fidelity Management and Research Company Foresite Capital Lightstone Ventures OrbiMed Suvretta Capital Management Wellington Management Wu Capital

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details